Molina Healthcare (MOH) Gets a Buy Rating from Morgan Stanley
Morgan Stanley analyst Ricky Goldwasser maintained a Buy rating on Molina Healthcare (MOH) today and set a price target of $172. The company’s shares closed last Monday at $129.59.
According to TipRanks.com, Goldwasser is a 4-star analyst with an average return of 4.3% and a 56.5% success rate. Goldwasser covers the Services sector, focusing on stocks such as Walgreens Boots Alliance, Quest Diagnostics Inc, and Laboratory Corp.
Molina Healthcare has an analyst consensus of Moderate Buy, with a price target consensus of $170.
See today’s analyst top recommended stocks >>
Molina Healthcare’s market cap is currently $8.13B and has a P/E ratio of 10.82. The company has a Price to Book ratio of 4.70.
Based on the recent corporate insider activity of 71 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of MOH in relation to earlier this year.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Molina Healthcare, Inc. engages in the provision of health care services. It operates through the Health Plans and Molina Medicaid Solutions segments. The Health Plans segment consists of health plans in 11 states and the Commonwealth of Puerto Rico and includes direct delivery business.